These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22154813)

  • 1. A brief assessment tool for body image in systemic lupus erythematosus.
    Jolly M; Pickard AS; Sequeira W; Wallace DJ; Solem CT; Mikolaitis RA; Fogg L; Weisman MH; Block JA; Cash TF
    Body Image; 2012 Mar; 9(2):279-84. PubMed ID: 22154813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body image in patients with systemic lupus erythematosus.
    Jolly M; Pickard AS; Mikolaitis RA; Cornejo J; Sequeira W; Cash TF; Block JA
    Int J Behav Med; 2012 Jun; 19(2):157-64. PubMed ID: 21380770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific patient reported outcome tools for systemic lupus erythematosus.
    Jolly M; Pickard AS; Block JA; Kumar RB; Mikolaitis RA; Wilke CT; Rodby RA; Fogg L; Sequeira W; Utset TO; Cash TF; Moldovan I; Katsaros E; Nicassio P; Ishimori ML; Kosinsky M; Merrill JT; Weisman MH; Wallace DJ
    Semin Arthritis Rheum; 2012 Aug; 42(1):56-65. PubMed ID: 22480408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
    Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
    Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure.
    Hassett AL; Li T; Radvanski DC; Savage SV; Buyske S; Schiff SA; Katz PP
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1341-8. PubMed ID: 22438284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
    Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.
    Bourré-Tessier J; Clarke AE; Kosinski M; Mikolaitis-Preuss RA; Bernatsky S; Block JA; Jolly M
    Lupus; 2014 Dec; 23(14):1452-9. PubMed ID: 25081500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between alexithymia and psychological factors in systemic lupus erythematosus.
    Barbosa F; Mota C; Patrício P; Alcântara C; Ferreira C; Barbosa A
    Compr Psychiatry; 2011; 52(6):754-62. PubMed ID: 21193176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus.
    McElhone K; Castelino M; Abbott J; Bruce IN; Ahmad Y; Shelmerdine J; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Gordon C; Teh LS
    J Rheumatol; 2010 Nov; 37(11):2273-9. PubMed ID: 20810500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature.
    Castelino M; Abbott J; McElhone K; Teh LS
    Rheumatology (Oxford); 2013 Apr; 52(4):684-96. PubMed ID: 23264550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
    Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in systemic lupus erythematosus: a controlled study.
    Abu-Shakra M; Mader R; Langevitz P; Friger M; Codish S; Neumann L; Buskila D
    J Rheumatol; 1999 Feb; 26(2):306-9. PubMed ID: 9972963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring dysmorphic concern in Italy: psychometric properties of the Italian Body Image Concern Inventory (I-BICI).
    Luca M; Giannini M; Gori A; Littleton H
    Body Image; 2011 Jun; 8(3):301-5. PubMed ID: 21664200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric validation of the Brief Pain Inventory-Short Form in patients with systemic lupus erythematosus in the United States.
    Naegeli AN; Tomaszewski EL; Al Sawah S
    Lupus; 2015 Nov; 24(13):1377-83. PubMed ID: 26038345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.
    Jolly M; Garris CP; Mikolaitis RA; Jhingran PM; Dennis G; Wallace DJ; Clarke A; Dooley MA; Parke A; Strand V; Alárcon GS; Kosinski M
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1542-50. PubMed ID: 24757021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alexithymia in systemic lupus erythematosus patients.
    Barbosa F; Mota C; Alves M; Alcântara C; Rossiñol B; Patrício P; Barbosa A; Ferreira C
    Ann N Y Acad Sci; 2009 Sep; 1173():227-34. PubMed ID: 19758155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.